
In its latest Enforcement Report, the US Food and Drug Administration (USFDA) noted that the Mumbai-based drug major is recalling 24,194 prefilled syringes of Fyremadel (ganirelix acetate) injection. The company is recalling the affected lot due to the presence of particulate matter, the USFDA said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1HESqul
via
IFTTT
0 comments:
Post a Comment